Kaliki S, Shields CL. Uveal melanoma: relatively rare but deadly cancer. Eye. 2017;31:241–57.

Article  CAS  PubMed  Google Scholar 

Rantala ES, Hernberg M, Kivelä TT. Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis. Melanoma Res. 2019;29:561.

Article  PubMed  PubMed Central  Google Scholar 

Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Archives of ophthalmology (Chicago, Ill.: 1960), 2006;124(12):1684–1693.

Wisely CE, Hadziahmetovic M, Reem RE, Hade EM, Nag S, Davidorf FH, et al. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy. Brachytherapy. 2016;15:12–22.

Article  PubMed  PubMed Central  Google Scholar 

Tarlan B, Kıratlı H. Uveal melanoma: current trends in diagnosis and management. Turkish J Ophthalmol. 2016;46:123.

Article  Google Scholar 

Zemba M, Dumitrescu O-M, Gheorghe AG, Radu M, Ionescu MA, Vatafu A, Dinu V. Ocular complications of radiotherapy in uveal melanoma. Cancers. 2023;15:333.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karimi S, Arabi A, Siavashpour Z, Shahraki T, Ansari I. Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis. J Contemp Brachytherapy. 2021;13:358–64.

Article  PubMed  PubMed Central  Google Scholar 

Damato BE. Treatment selection for uveal melanoma. Curr Concepts Uveal Melanoma. 2012;49:16–26.

Article  Google Scholar 

Marucci L, Ancukiewicz M, Lane AM, Collier JM, Gragoudas ES, Munzenrider JE. Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation. Int J Radiation Oncology* Biology* Phys. 2011;79:842–6.

Article  Google Scholar 

Weber B, Paton K, Ma R, Pickles T. Outcomes of proton beam radiotherapy for large non-peripapillary choroidal and ciliary body melanoma at TRIUMF and the BC cancer agency. Ocular Oncol Pathol. 2015;2:29–35.

Article  Google Scholar 

Foti PV, Travali M, Farina R, Palmucci S, Spatola C, Liardo RLE, et al. Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging—part II: treatment indications and complications. Insights into Imaging. 2021;12:1–24.

Google Scholar 

Grech Fonk L, Ferreira TA, Webb AG, Luyten GPM, Beenakker JM. The economic value of MR-imaging for uveal melanoma. Clinical ophthalmology (Auckland, N.Z.), 2020;14:1135–1143.

Wang Z, Nabhan M, Schild SE, Stafford SL, Petersen IA, Foote RL, Murad MH. Charged particle radiation therapy for uveal melanoma: a systematic review and meta-analysis. Int J Radiation Oncology* Biology* Phys. 2013;86:18–26.

Article  Google Scholar 

Gragoudas ES, Goitein M, Koehler AM, Verhey L, Tepper J, Suit HD, et al. Proton irradiation of small choroidal malignant melanomas. Am J Ophthalmol. 1977;83:665–73.

Article  CAS  PubMed  Google Scholar 

Aziz S, Taylor A, McConnachie A, Kacperek A, Kemp E. Proton beam radiotherapy in the management of uveal melanoma: Clinical experience in Scotland. Clin Ophthalmol. 2009;3:49–55.

Hrbacek J, Kacperek A, Beenakker JM, Mortimer L, Denker A, Mazal A, Shih HA, Dendale R, Slopsema R, Heufelder J, Mishra KK, Hrbacek J, Kacperek A, Beenakker JM, Mortimer L, Denker A, Mazal A, Shih HA, Dendale R, Slopsema R, Heufelder J, Mishra KK. PTCOG ocular statement: Expert summary of current practices and future developments in ocular proton therapy. Int J Radiation Oncol Biol Phys. 2024;120(5):1307–1325.

Hrbacek J, Mishra KK, Kacperek A, Dendale R, Nauraye C, Auger M, et al. Practice patterns analysis of ocular proton therapy centers: the international OPTIC survey. Int J Radiation Oncology* Biology* Phys. 2016;95:336–43.

Article  Google Scholar 

Slopsema R, Mamalui M, Zhao T, Yeung D, Malyapa R, Li Z. Dosimetric properties of a proton beamline dedicated to the treatment of ocular disease. Med Phys. 2014;41:011707.

Article  CAS  PubMed  Google Scholar 

Tran E, Ma R, Paton K, Blackmore E, Pickles T. Outcomes of proton radiation therapy for peripapillary choroidal melanoma at the BC cancer agency. Int J Radiation Oncology* Biology* Phys. 2012;83:1425–31.

Article  Google Scholar 

Maillie L, Lazarev S, Simone CB, Sisk M. Geospatial disparities in access to proton therapy in the continental United States. Cancer Invest. 2021;39:582–8.

Article  PubMed  Google Scholar 

Engwall E, Battinelli C, Wase V, Marthin O, Glimelius L, Bokrantz R, et al. Fast robust optimization of proton PBS arc therapy plans using early energy layer selection and spot assignment. Phys Med Biol. 2022;67:065010.

Article  CAS  Google Scholar 

Ding X, Li X, Zhang JM, Kabolizadeh P, Stevens C, Yan D. Spot-scanning proton arc (SPArc) therapy: the first robust and delivery-efficient spot-scanning proton arc therapy. Int J Radiation Oncology* Biology* Phys. 2016;96:1107–16.

Article  Google Scholar 

Seco J, Gu G, Marcelos T, Kooy H, Willers H. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer. Int J Radiation Oncology* Biology* Phys. 2013;87:188–94.

Article  Google Scholar 

Sanchez-Parcerisa D, Kirk M, Fager M, Burgdorf B, Stowe M, Solberg T, Carabe A. Range optimization for mono-and bi-energetic proton modulated arc therapy with pencil beam scanning. Phys Med Biol. 2016;61:N565.

Article  CAS  PubMed  Google Scholar 

Liu G, Li X, Zhao L, Zheng W, Qin A, Zhang S, et al. A novel energy sequence optimization algorithm for efficient spot-scanning proton arc (SPArc) treatment delivery. Acta Oncol. 2020;59:1178–85.

Article  CAS  PubMed  Google Scholar 

Li X, Kabolizadeh P, Yan D, Qin A, Zhou J, Hong Y, et al. Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy. Radiat Oncol. 2018;13:1–9.

Article  Google Scholar 

Chang S, Liu G, Zhao L, Dilworth JT, Zheng W, Jawad S, et al. Feasibility study: spot-scanning proton arc therapy (SPArc) for left-sided whole breast radiotherapy. Radiat Oncol. 2020;15:1–11.

Article  Google Scholar 

Tattenberg S, Liu P, Mulhem A, Cong X, Thome C, Ding X. Impact of and interplay between proton arc therapy and range uncertainties in proton therapy for head-and-neck cancer. Phys Med Biol. 2024;69(5). https://doi.org/10.1088/1361-6560/ad2718.

de Jong BA, Korevaar EW, Maring A, Werkman CI, Scandurra D, Janssens G, et al. Proton arc therapy increases the benefit of proton therapy for oropharyngeal cancer patients in the model based clinic. Radiother Oncol. 2023;184:109670.

Article  PubMed  Google Scholar 

Langner UW, Eley JG, Dong L, Langen K. Comparison of multi-institutional varian probeam pencil beam scanning proton beam commissioning data. J Appl Clin Med Phys. 2017;18:96–107.

Article  PubMed  PubMed Central  Google Scholar 

Newhauser WD, Koch NC, Fontenot JD, Rosenthal SJ, Gombos DS, Fitzek MM, Mohan R. Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy. Phys Med Biol. 2007;52:3979.

Article  PubMed  Google Scholar 

Yeung D, McKenzie C, Indelicato DJ. A dosimetric comparison of intensity-modulated proton therapy optimization techniques for pediatric craniopharyngiomas: a clinical case study. Pediatr Blood Cancer. 2014;61:89–94.

Article  PubMed  Google Scholar 

Shirey RJ, Wu HT. Quantifying the effect of air gap, depth, and range shifter thickness on TPS dosimetric accuracy in superficial PBS proton therapy. J Appl Clin Med Phys. 2018;19:164–73.

Article  PubMed  Google Scholar 

Lin L, Huang S, Kang M, Hiltunen P, Vanderstraeten R, Lindberg J, et al. A benchmarking method to evaluate the accuracy of a commercial proton Monte Carlo pencil beam scanning treatment planning system. J Appl Clin Med Phys. 2017;18:44–9.

Article  PubMed  PubMed Central  Google Scholar 

Feuvret L, Noël G, Mazeron J-J, Bey P. Conformity index: a review. Int J Radiation Oncology* Biology* Phys. 2006;64:333–42.

Article  Google Scholar 

Tsai P, Tseng Y-L, Shen B, Ackerman C, Zhai HA, Yu F, et al. The applications and pitfalls of cone-beam computed tomography-based synthetic computed tomography for adaptive evaluation in pencil-beam scanning proton therapy. Cancers. 2023;15:5101.

Article  PubMed  PubMed Central  Google Scholar 

Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau D, et al. SciPy 1.0: fundamental algorithms for scientific computing in python. Nat Methods. 2020;17:261–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaiser A, Eley JG, Onyeuku NE, Rice SR, Wright CC, McGovern NE, Sank M, Zhu M, Vujaskovic Z, Simone CB 2nd, Hussain A. Proton therapy delivery and its clinical application in select solid tumor malignancies. J Visual Experiment. 2019;JoVE(144). https://doi.org/10.3791/58372.

Ding X, Li X, Qin A, Zhou J, Yan D, Stevens C, et al. Have we reached proton beam therapy dosimetric limitations?–a novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer. Acta Oncol. 2018;57:435–7.

Article  PubMed  Google Scholar 

Dendale R, Lumbroso-Le Rouic L, Noel G, Feuvret L, Levy C, Delacroix S, et al. Proton beam radiotherapy for uveal melanoma: results of curie Institut–Orsay proton therapy center (ICPO). Int J Radiation Oncology* Biology* Phys. 2006;65:780–7.